Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating multiple sclerosis using antisense oligonucleotides

Methods for treating multiple sclerosis using antisense oligonucleotides

US Patent 11891606 · Granted Feb 6, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic uses and methods2024
Mobilizing leukemia cells2021
Modulation of growth hormone receptor expression and insulin-like growth factor 2018
Method for reducing circulating leukocytes in a human subject2018
Combination therapy2017
Combination therapy2017
Modulation of growth hormone receptor expression and insulin-like growth factor 2016
Modulation of insulin like growth factor I receptor expression in cancer2015
Topical administrations of antisense compounds to VLA-4 for the treatment of res2014
Methods for treating multiple sclerosis using antisense oligonucleotides2014
Modulation of growth hormone receptor expression and insulin-like growth factor 2014
Modulation of growth hormone receptor expression and insulin-like growth factor 2014